Study of EMB-001 as a Potential Smoking Cessation Treatment

Clinical trial NCT04933916 · TERMINATED

Trial details

NCT number: NCT04933916
Sponsor: Embera NeuroTherapeutics, Inc.
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Tobacco Use Disorder

Start date: 2021-06-10
Primary completion: 2023-04-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.